We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SCMN:SIXSwisscom AG Analysis

Data as of 2026-09-06 - not real-time

CHF 633.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Swisscom AG is priced at CHF 633.50, and its moving averages give no clean directional read — the structure is neutral. It has gained 1.8% over the past 30 days. Momentum indicators put RSI at 51.7 (neutral) with MACD reading bearish. Price has been bracketed by support at CHF 620.50 and resistance at CHF 643.50.
On valuation the read is overvalued — earnings multiple of 24.9 versus a 15.5 sector average, above the peer group. Sell-side targets cluster 9.1% below the current quote. Revenue is contracting at 2.0% on a 8.9% profit margin. The 4.10% dividend yield looks stretched against payout coverage.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 19.3%, a beta of 0.06 and a maximum drawdown of 16.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to sell, carrying 6/10 conviction.

Top Market Events

Swisscom stock reflects 2025 earnings of CHF 11.Swisscom stock trades above the average analyst target after the latest half-year report showed stabSwisscom stock traded modestly lower on the SIX Swiss Exchange on August 21, 2026, but the shares co

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Trading below the 200-day average of 640.08
  • MACD momentum is negative
  • RSI at 51.7 is in neutral territory

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • P/E of 24.9 versus sector average of 15.5
  • Dividend yield of 4.10% looks stretched against payout coverage
  • Trading below the 200-day average of 640.08

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • P/E of 24.9 versus sector average of 15.5
  • Dividend yield of 4.10% looks stretched against payout coverage
  • Analyst targets imply -9.1% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth-2.00%
Profit Margin8.86%
P/E Ratio24.9
ROE11.36%
ROA3.54%
Debt/Equity143.29
P/B Ratio2.8
Op. Cash FlowCHF6.1B
Free Cash FlowCHF2.7B
Industry P/E15.5

Technical Analysis

TrendNeutral
RSI51.7
SupportCHF 620.50
ResistanceCHF 643.50
MA 20CHF 632.75
MA 50CHF 627.48
MA 200CHF 640.08
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

Fair ValueCHF 354.53
Target PriceCHF 575.76
Upside/Downside-9.11%
GradeOvervalued
TypeValue
Dividend Yield4.10%

Risk Assessment

Beta0.06
Volatility19.27%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.